Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 34Small Cell Lung Carcinoma 14Triple Negative Breast Neoplasms 12Breast Neoplasms 9Ovarian Neoplasms 8Lung Neoplasms 7Endometrial Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Esophageal Neoplasms 4NSCLC 3Esophageal Squamous Cell Carcinoma 3Carcinoma 3Uterine Cervical Neoplasms 2Recurrence 2Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Fallopian Tube Neoplasms 2Brain Neoplasms 2Unresectable Locally Advanced or Metastatic Solid Tumors 1Thymoma 1Thymic epithelial tumor 1Stomach Neoplasms 1Stage III and IV Ovarian Cancer 1Squamous Non-small Cell Lung Cancer 1Squamous NSCLC 1Solid Tumor Cancer 1Solid Tumor 1Salivary Gland Malignant Neoplasms 1Respiratory Tract Neoplasms 1

Interventions

Fluorodeoxyglucose F18 2toripalimab 1spartalizumab 1sintilimab 1osimertinib 1olaparib 1apatinib 1Ink 1Histocompatibility Testing 1Carboplatin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Solid Tumor × Carboplatin × Clear all
NCT07612137 2026-05-28

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1/2 Not yet recruiting
282 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡